Citius Pharmaceuticals (CTXR) Stock Chart & Stock Price History $1.03 -0.15 (-12.71%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$1.06 +0.03 (+3.40%) As of 04/3/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Citius Pharmaceuticals Stock Price Performance 5 Day Performance-33.55%1 Month Performance-33.97%3 Month Performance-74.12%6 Month Performance-90.75%Year-To-Date Performance-74.25%1 Year Performance-95.73% Receive CTXR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address CTXR Stock Chart for Friday, April, 4, 2025 CTXR Chart by TradingViewRemove Ads Citius Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/03/2025$1.18$1.03-12.71%$1.16$0.99370,061 shs$8.85 million04/02/2025$1.20$1.18-1.67%$1.23$1.15256,859 shs$10.14 million04/01/2025$1.49$1.20-19.46%$1.34$1.18654,339 shs$10.31 million03/31/2025$1.55$1.49-3.87%$2.28$1.409.35 million shs$12.80 million03/28/2025$1.30$1.55+19.23%$1.72$1.25656,271 shs$13.32 million03/27/2025$1.36$1.30-4.41%$1.38$1.21130,396 shs$11.17 million03/26/2025$1.47$1.36-7.48%$1.49$1.3593,277 shs$11.69 million03/25/2025$1.55$1.47-5.16%$1.57$1.4176,779 shs$12.63 million03/24/2025$1.52$1.55+1.97%$1.62$1.5181,744 shs$13.32 million03/21/2025$1.55$1.52-1.94%$1.59$1.5056,070 shs$13.06 million Get the Latest News and Ratings for CTXR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 03/20/2025$1.61$1.55-3.73%$1.66$1.5542,439 shs$13.32 million03/19/2025$1.64$1.61-1.83%$1.69$1.5963,462 shs$13.84 million03/18/2025$1.53$1.64+7.19%$1.70$1.5251,927 shs$14.09 million03/17/2025$1.50$1.53+2.00%$1.55$1.4844,142 shs$13.15 million03/14/2025$1.55$1.50-3.23%$1.58$1.4846,767 shs$12.89 million03/13/2025$1.59$1.55-2.52%$1.70$1.5261,834 shs$13.32 million03/12/2025$1.61$1.59-1.24%$1.65$1.5547,678 shs$13.66 million03/11/2025$1.58$1.61+1.90%$1.64$1.5548,550 shs$13.84 million03/10/2025$1.79$1.58-11.73%$1.87$1.58113,305 shs$13.58 million03/07/2025$1.78$1.79+0.56%$1.85$1.7164,818 shs$15.38 million03/06/2025$1.70$1.78+4.71%$1.88$1.6486,749 shs$15.30 million03/05/2025$1.61$1.70+5.59%$1.71$1.5556,965 shs$14.61 million03/04/2025$1.56$1.61+3.21%$1.61$1.5087,306 shs$13.84 million03/03/2025$1.65$1.56-5.45%$1.70$1.5474,689 shs$13.41 million Related Companies CTMX Stock Chart MGX Stock Chart GANX Stock Chart ALGS Stock Chart ADAP Stock Chart KRON Stock Chart ATNM Stock Chart TNYA Stock Chart FBRX Stock Chart SKYE Stock Chart Receive CTXR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CTXR) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredNearly $3 Trillion Gone…Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow you could profit from Elon’s latest AI breakthroughEvery single one of Elon's projects minted an entire new class of millionaires. And xAI could be next in li...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Citius Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Citius Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
